Cerebras Raises FY2026 Revenue Outlook After Q3 Results
Cerebras Systems Inc. (NASDAQ:CBRS) posted downbeat third-quarter fiscal 2026 results but raised its forward guidance on Thursday. Cerebras reported quarterly losses of 67 cents per share, which missed the consensus estimate for a loss of 14 cents, per Pro data. Record GAAP revenue of $210.8 million missed the Street estimate of $214.7 million. Core revenue was a record $230.9 million. "Cerebras’ technology remains the undisputed champion of speed," said Andrew Feldman, CEO of Cerebras. "We’re giving customers more ways to access our technology and scale with us be it through direct system sales, Cerebras Cloud or third-party cloud providers." Cerebras raised its fiscal 2026 revenue outlook to between $940 million and $960 million, compared to the $887.04 million analyst estimate. Cerebras Systems shares gained 11.2% to close at $108.72 on Friday. These analysts made changes to their...
Cerebras Systems Inc. (NASDAQ:CBRS) posted downbeat third-quarter fiscal 2026 results but raised its forward guidance on Thursday. Cerebras reported quarterly losses of 67 cents per share, which missed the consensus estimate for a loss of 14 cents, per Pro data. Record GAAP revenue of $210.8 million missed the Street estimate of $214.7 million.
Core revenue was a record $230.9 million. "Cerebras’ technology remains the undisputed champion of speed," said Andrew Feldman, CEO of Cerebras. "We’re giving customers more ways to access our technology and scale with us be it through direct system sales, Cerebras Cloud or third-party cloud providers." Cerebras raised its fiscal 2026 revenue outlook to between $940 million and $960 million, compared to the $887.04 million analyst estimate. Cerebras Systems shares gained 11.2% to close at $108.72 on Friday.
These analysts made changes to their price targets on Cerebras Systems following earnings announcement. Needham analyst N. Quinn Bolton maintained the stock with a Buy and lowered the price target from $300 to $200. UBS analyst Timothy Arcuri maintained the stock with a Buy and lowered the price target from $250 to $155.
Mizuho analyst Vijay Rakesh maintained the stock with an Outperform rating and cut the price target from $300 to $240. Considering buying CBRS stock? Here’s what analysts think: Photo via Shutterstock